Abstract. The binding activity of the AP-1 FOS/JUN complex to a negative regulatory element on the c-myc promoter was investigated and correlated with events characteristic of terminal differentiation of HMBA-induced mouse erythroleukemic cells. It is suggested that the altered AP-1 activity that was found upon induction of the erythroid differentiation may contribute to the late decline in c-myc mRNA.
Introduction
The c-myc proto-oncogene encodes for two highly conserved nuclear phosphoproteins p62 and p64 involved in cellular proliferation and differentiation (1) . c-myc expression may be controlled at at least four levels (reviewed in ref. 2) . First, at the level of transcription initiation through four separate RNA start sites (PO, PI, P2 and P3). Furthermore, a block in transcriptional elongation has been observed during differentiation of HL60 human promyelocytic leukemia (3) and MEL cells (4) , while mRNA stability may be another important mechanism of regulation as demonstrated for murine plasmacytomas (5) . Finally, expression of the murine c-myc gene appears also to be controlled at the level of mRNA translation (6) .
Transcriptional regulation of c-myc is extremely complex and is modulated by both positive and negative c/s-acting regulatory elements. The role of regulatory elements located within 5' flanking sequences and within exon I of c-myc are not only important for the regulation of transcription from PO, PI and P2 (7) (8) (9) (10) (11) but also for premature termination of transcripts (12) and translational control (6) . Key words: FOS/JUN binding activity, c-myc oncogene, erythroleukemic cells differentiation (13) . When these cells are exposed to HMBA or a variety of other chemicals, they reinitiate a program of erythroid differentiation, culminating in hemoglobin synthesis and terminal cell division (13) . During the differentiation process, a biphasic change in c-myc and c-myb mRNAs is observed (14, 15) . Alterations in c-fos, K-ras and p53 gene expression have also been reported in some but not all FLC lines (15, 16) .
The c-fos oncogene is known to participate in transcriptional regulation through formation of a c-fos:c-jun heterodimer protein known as the AP-1 complex (for a review see ref. 17 ). The AP-1 complex has been reported to participate in the process of differentiation ( 18) and may also control the expression of genes involved in cellular proliferation (17) . Since an AP-1 binding site has been found within the c-myc promoter (19) , it was of interest to study the levels of AP-1 complex bound to that region during HMBAinduced erythroid differentiation. Our data suggests that differential AP-1 binding may represent a possible mechanism (or part of a mechanism) which regulates c-myc expression during this process.
Materials and methods
Cell lines and culture conditions. The F412B2TK mouse erythroleukemic (Friend) cells and the HeLa cell line used in this study, were continuously maintained in RPMI-I640 (Gibco) with 50 μg/ml streptomycin and 300 μg/ml penicillin, supplemented with 10% Fetal Calf Serum (Flow), at 37°C in a 5% C0 2 atmosphere.
Erythroid differentiation was achieved by exposing FLC to 3 mM HexaMethyleneBisAcetamide (HMBA, Sigma) dissolved in water.
Hemoglobin quantitation. Hemoglobin content of induced and non-induced cells was estimated using the method of Rutherford (20) , as modified. 10 7 cells exposed to 3 mM HMBA for various time intervals (0, 24, 48, 72, 96 and 120 h) were centrifuged (700 χ g, 5 min, 4°C) and washed with PBS twice. After removing the supernatant, the pellet was lysed in 1 ml distilled water and two cycles of freeze (-70°C) and thaw (37°C). Centrifugation at 12000 χ g for 5 min at 4°C gave a clear supernatant which was used immediately for photometric estimation of hemoglobin at wavelength range of 405-420 nm and quantitation at 414 nm, in a LKB 4054 spectrophotometer.
Extraction of total RNA and Northern blot analysis. RNA extracts from differentiated and non-differentiated cells were prepared as described by Sambrook et al (21 ) .
Briefly, cells were harvested (700 χ g, 5 min, 4°C). washed with PBS and the pellet was then lysed in guanidinium thiocyanate solution. After phenol/chloroform/ isoamylalcohol extraction, the aqueous phase was removed, an equal volume of isopropanol was added and left for 1 h at -20°C. Centrifugation at 12,000 χ g for 25 min at 4°C gave a RNA pellet which was rinsed in 70% ethanol, dried in vacuum and resuspended in RNase-free water. We estimated the RNA concentration photometrically at 260 nm.
12 μg of each RNA sample were incubated with a solution containing 2 μΐ 5 χ MOPS, 3.5 μΐ formaldehyde and 10 μΐ formamide in a final volume of 20 μ], at 65°C for 15 min.
Samples were then loaded in a 1 % formaldehyde gel and run for approximately 4 h at 80V in a MOPS/formaldehyde running buffer.
For Northern blotting we followed the Hybond-N+ protocol (Amersham) using 20 X SSPE buffer. After blotting, RNA was fixed by baking the membrane at 80°C for 2 h.
Pre-hybridization with 5 X SSPE, 5 χ Denhardt's solution 50 % formamide and 0.5% (w/v) SDS for 6 h in 42°C, was followed by overnight hybridization. The probes used were the 7.0 Kb EcoRI/EcoRI fragment of plasmid pBRMßG-6 carrying the mouse ß-globin gene, the 1.4 Kb Clal/EcoRI fragment of plasmid pMC41-3RC, carrying the third exon (EHI) of the human c-myc gene and the 3 Kb Xhol/Ncol fragment of plasmid pc-fos, carrying the human c-fos gene. Mouse ß-actin DNA was a gift from Dr E. Gonos (Ludwig Institute for Cancer Research, London, UK). All DNAinserts were labelled with ,: P dCTP (Amersham) using the random primed DNA labelling kit of Boehringer Mannheim.
The membranes were finally washed twice in 2 X SSPE, 0.1% SDS in room temperature for 30 min, twice in 1 X SSPE, 0,1% SDS for 20 min at 42°C and once in 0.5 X SSPE, 0.1% SDS in 42°C for 15 min, followed by exposure to X-ray film (Fuji) with an intensifying screen.
Preparation of nuclear extracts. Nuclear extracts from F412B2TK" and HeLa cells were prepared as previously described (22) . Briefly, cells were harvested (700 χ g, 5 min, 4°C), washed with PBS and dried. The cell pellets were homogenised with a B-type dounce homogenizer in hypotonic buffer (25 mM Tris.HCl pH=7.5, 5 mM KCl, 0.5 mM MgCL, 0.5 mM dithiothreitol (DTT) and 0.5 mM PMSF), centrifuged at 2,000 χ g, washed three times with isotonic buffer (25 mM Tris.HCl pH=7.5, 5 mM KCl, 0.5 mM MgCL, 0.1 M surcose, 0.5 mM DTT and 0.5 mM PMSF), and resuspended in nuclei extraction buffer (25 mM Tris.HCl pH=7.5, 1 mM EDTA. 0.1% Triton X-100, 0.5 m M DTT, 0.5 mM PMSF and 0.6 M KCl). Nuclei were inverted slowly for 30 min and the extract clarified by centrifugation at 2.5 χ IO 4 g for 60 min at 4°C. Nuclear extracts were stored at -70°C. Protein estimations were performed using Biorad Protein Assay (Biorad). (Fig. 1) . Both oligonucleotides were synthesized on an Applied Biosystems 381A DNA synthesizer.
Single stranded complementary oligonucleotides were annealed, end-labelled using γ-32 Ρ-ΑΤΡ (Amersham) and T4 polynucleotide kinase (Boehringer) and run on a 8% Polyacrylamide gel to test that the annealing had worked.
The binding reaction mixture contained 10 mM Hepes (pH=7.9), 0.2 mM EDTA, 94 mM NaCl, 0.1 mM PMSF, 0.1 ng/ml BSA, 4% glycerol, 3 μg poly(dl-dC) (Pharmacia), 0.2-1.0 ng 32 P labelled DNA and 20 μg nuclear extracts (exept when otherwise indicated). Incubation was on ice for 30 min. Then, reaction mixtures were loaded onto a 5% Polyacrylamide gel (29:1 acrylamide: N,N'-methylene bisacrylamide, Serva). Gels were run at 4°C in 0.55 X TBE, dried and exposed to X-ray film for autoradiography (Fuji).
FOS 388 and JUN 948 antibodies used in this study were a generous gift of Dr D.A.F. Gillespie (Beatson Institute for Cancer Research, Glasgow, UK).
Assay for cell proliferation. Cell proliferation was estimated using the rapid colorimetrie assay of Mossman (24) as previously described (25) . In brief, 10 μΐ of MTT [3-(4,5-dimethylthiazol 2-yl)-2,5 -diphenyl tetrazolium bromide] (Sigma) in PBS were added to 100 μΐ complete medium in a Costar 96 well plate containing F412B2TK cells exposed to 3 mM HMBA for various lengths of time (0, 24, 48, 72, 96 and 120 h). After incubation for 4 h at 37°C, 110 μΐ of 0.04 HCl in isopropanol were added. Optical Density (O.D) was recorded at 540 nm using a Titertek Flow Micro ELIZA reader.
Results
Exposure of mouse erythroleukemic cells to HMBA results in alteration of expression of several genes, the most characteristic of which are the globin genes. In order to examine whether the differentiated process had occurred in our system, we performed Northern blot analysis of total RNA isolated from differentiated (days 1 to 5) and nondifferentiated cells. As depicted in Fig. 2a . a dramatic increase in ß-globin expression was observed during the differentiation process, followed by hemoglobin production. Hemoglobin gives a characteristic peak in 413-414 nm (20) which becomes obvious as early as the second day of differentiation (Fig. 3) . No significant differences in globin gene expression were observed between days 4 and 5 after the initiation of drug exposure. Growth arrest, which is another characteristic of finally differentiated cells was demonstrated by a rapid cell proliferation assay for various times intervals (0. 24, 48. 72. 96 and 120 h) (Fig. 4) .
c-myc is one of the oncogenes that respond early to induction of differentiation and presents a marked decrease in its expression during the final steps of differentiation of FI.C cells, as depicted in Fig. 2b . The c-fos oncogene is up- regulated as early as 24 h post-induction but its levels remain constant thereafter (Fig. 2c) .
We further investigated the alteration in AP-1 levels bound to AP-1 site of c-myc promoter. When crude extracts from HeLa cells were incubated with labelled wycAP-1 oligo (Fig. 1) , three protein-DNA complexes formed (a, b and c. Fig. 5, lanes 5,6 ) which is consistent with previous reports (19, 26) . On the contrary, when the same extracts were incubated with E3AP1 oligo, only the two, slower migrating a, b complexes were formed (lanes 1 and 2, Fig. 5) . A similar pattern of protein binding was observed with extracts from Friend leukemic cells (FLC) F412B2TK" (Fig. 5, lanes 3.4  and 7,8) .
Among the three protein-wvc oligo complexes, only the b complex has been shown to be an AP-1 (FOS/JUN) (19) . Indeed, in gel retardation experiments. FOS and JUN antibodies eliminated the b-band in extracts of both differentiated and finally differentiated (day 4) FLC (Fig. 6 , (Fig. 6, lanes 3-5) . Finally, we used end-labelled myc AP-1 oligo to study the binding activity of AP-1 during HMBA-induced differentiation of FLC. Cell extracts from FLC induced with 3 mM HMBA or non-induced were incubated with the myc AP-\ probe. As shown in Fig. 7 , a dramatic increase in AP-1 binding is observed during the first 72 h, followed by a drop at 96 and 120 h post-induction. Similar results were obtained in two other independent experiments, while in another, the peak of binding was observed on day 2 (48 h) after induction, probably reflecting cell-cycle effects.
In order to further certify that the altered protein binding was indeed AP-1, we repeated the experiment described above, using E 3 AP-1 probe instead of mycAP-1. As shown in Fig. 8 , the same binding pattern was observed, except that there was no formation of the complex c. although cells are not yet committed irreversibly to differentiate, that is, they can not undergo the program of terminal cell division and gene expression upon removal of HMBA from the culture. In the presence of HMBA more than 90% of the cells are committed after 48-60 h exposure to HMBA (15) . Induction of globin genes is observed after 24 h (Fig. 2a and 3 ) while irreversible cessation of proliferation occurs 72 to 96 h post-induction (Fig. 4) . Nuclear oncogenes, especially c-myc and c-myb, show a biphasic change in their expression, which may be correlated with the commitment of FLC to differentiate. Constitutive cmyc expression blocks differentiation but not commitment (27) , probably by interfering at a point prior to or close to the commitment (28) . Taking also into account that the late but not the early decline in mRNA, coincides well with the change of protein level (29) , commitment may require regulatable expression of c-myc whereas induction to differentiation may require only the late decline in c-myc mRNA (28) . The mechanism of c-myc down regulation in both cases is complicated and both transcriptional and posttranscriptional control have been reported (4, 16, 30) . Since a promoter-driven regulation has been suggested for c-myc expression during the differentiation of F412B2(TK ) Friend erythroleukemia cells (16) , it was of interest to study the binding activity of FOS/JUN (AP-1) complex on a c-myc negative regulatory element found to contain an AP-1 binding site (19) . The NRE domain of c-myc has been previously shown to be important for c-myc expression after anthracycline (25) and platinum compound (31) exposure of Friend cells.
Among the three factors bound to the NRE domain of cmyc, the AP-1 complex and the ubiquitous octamer-binding factor have been identified (Fig. 5, bands b and a,  respectively) (19, 26) . These two complexes bind to highly overlapping segments of the c-myc sequence but do not cross-compete (26) . In agreement with these experimental data, we observed no alteration in binding activity of either octamer-binding factor or the unidentified complex c (Fig. 5  and 7 ) on wycAP-1 oligo, indicating that any effect exerted from myc NRE during differentiation of F412B2TK" cells could be explained in terms of FOS/JUN altered levels bound to the AP-1 site.
In previous studies, FOS antibodies and in vitro translated FOS and JUN proteins were used to certify that the specific factor which binds to the AP-1 site of the NRE of c-myc is a FOS/JUN complex (19, 26) . We showed that JUN antibody also inhibits the binding of AP-1 complex to myc NRE (Fig.  6, lanes 8 and 11) , further supporting that the components of the nuclear factor with AP-1 binding capacity are the FOS and JUN proteins.
FOS and JUN proteins have been proposed as possible contributors to the repression of c-myc, through binding to m^c-NRE (19) . Reciprocal regulation of c-myc and c-fos has been observed during differentiation of a murine myeloid leukemia cell line; c-myc expression ceases as those cells differentiate, whereas c-fos is activated (32) . It has also been shown that induction of c-myc by mitogens begins only after expression of c-fos begins to decline (33) . Similarly, we showed that c-myc is down-regulated while c-fos mRNA levels become higher in differentiated than non-differentiated FL cells (Fig. 2, lanes b and c) . Nevertheless, regulation of fos and jun expression is complex and both transcriptional and post-transcriptional control could contribute to the final AP-1 activity (17) . Since there is a clear increase in AP-1 binding to the c-myc AP-1 site (Fig. 7) we propose that FOS/JUN complex may contribute to down regulation of cmyc during the HMBA-induced differentiation of FL cells. Furthermore, since the increase of binding is observed during the first 3 days of induction, at or before cellular terminal division and gene expression (Figs. 2, 4 and 7) we conclude that the increased binding of AP-1 followed by a drop on days 4 and 5 may contribute to repression of c-myc, which is most prominent during the last days of exposure to HMBA, and that repression may, in turn, be correlated with the terminal differentiation steps. Recent results, suggesting that induction to differentiation but not commitment may require the late decline in c-myc mRNA, are in agreement with such a correlation (28) .
